Suggested underlying mechanisms for these functions, at least in hepatocellular carcinoma, involve the phosphoinositide-3-kinase-protein kinase B/Akt (PI3K/Akt) and RAS/RAF/MEK/ERK pathways [65, 66]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.